Bionano Genomics (BNGO) Expected to Announce Quarterly Earnings on Thursday

Bionano Genomics (NASDAQ:BNGO) is expected to post its Q2 2025 quarterly earnings results after the market closes on Thursday, August 14th. Analysts expect Bionano Genomics to post earnings of ($2.69) per share and revenue of $6.90 million for the quarter. Bionano Genomics has set its Q2 2025 guidance at EPS.

Bionano Genomics (NASDAQ:BNGO) last posted its quarterly earnings results on Wednesday, May 14th. The company reported ($1.15) earnings per share for the quarter, beating the consensus estimate of ($3.49) by $2.34. The company had revenue of $6.46 million during the quarter, compared to analyst estimates of $6.25 million. Bionano Genomics had a negative net margin of 294.05% and a negative return on equity of 125.75%.

Bionano Genomics Price Performance

BNGO opened at $2.93 on Tuesday. The firm has a market cap of $9.84 million, a P/E ratio of -0.02 and a beta of 2.06. The firm has a 50-day moving average of $3.35 and a 200 day moving average of $3.85. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.34 and a current ratio of 1.70. Bionano Genomics has a fifty-two week low of $2.68 and a fifty-two week high of $37.09.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of Bionano Genomics from a “sell” rating to a “hold” rating in a research report on Saturday. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $7.00.

Bionano Genomics Company Profile

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.